(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEXTCELL MEDICAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NEXTCELL MEDICAL

ST13

US500000085951837

Class

3, 5

Filing

85951837

Registration

4614666

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

02/27/2025

Trademark type

Combined

Nice classes

3, 5

Filing date

06/05/2013

Registration date

09/30/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/30/2024

Last transaction

02/27/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2013-11-00

First use in commerce

2013-11-00

Drawing code

5

Owner type

03

Owner location

Pittsburgh, PA

Examiner

WEBSTER,WILLIAM M

Mark description

The mark consists of the words "NEXTCELL MEDICAL" with a stylized letter "X" in "Nextcell".

Holders and representatives

Holders

Nextcell Medical Company

Representatives

Kathryn Starshak K&L GATES LLP

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Skin care productsnon-medicated skin care preparationsnon-medicated skin creams and lotions

Class 5

Supplementsdietary supplementsvitamin supplements; medicated skin care preparations

Publications

History of USPTO decisions and trademark events.

36 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

08/30/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/30/2024

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

08/30/2024

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

08/30/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/30/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

06/17/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/30/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/03/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/03/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/03/2020

E815

TEAS SECTION 8 & 15 RECEIVED

09/10/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/30/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

09/30/2014

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/29/2014

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/28/2014

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/14/2014

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/05/2014

IUAF

USE AMENDMENT FILED

07/17/2014

EISU

TEAS STATEMENT OF USE RECEIVED

07/17/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/06/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/11/2014

PUBO

PUBLISHED FOR OPPOSITION

03/11/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/19/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/31/2014

ALIE

ASSIGNED TO LIE

01/30/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/03/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/03/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/03/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/18/2013

GNRT

NON-FINAL ACTION E-MAILED

09/18/2013

CNRT

NON-FINAL ACTION WRITTEN

09/18/2013

DOCK

ASSIGNED TO EXAMINER

09/17/2013

MPMK

NOTICE OF PSEUDO MARK E-MAILED

06/15/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/14/2013

NWAP

NEW APPLICATION ENTERED

06/08/2013

Continuous trademark protection

Get notified about every new filing that threatens NEXTCELL MEDICAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.